Lumos Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 744,513 | $2.88 M | 2,380.64% | 8.94% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 362,198 | $1.40 M | -10.92% | 4.35% |
| VANGUARD GROUP INC | 11/13/2024 | 244,082 | $944,597 | 0.00% | 2.93% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 213,814 | $827,460 | -0.93% | 2.57% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 120,651 | $466,919 | 0.00% | 1.45% |
| GREENWICH WEALTH MANAGEMENT LLC | 10/29/2024 | 76,341 | $295,000 | 0.00% | 0.92% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 64,981 | $251,475 | -84.34% | 0.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 55,148 | $213,459 | 8.72% | 0.66% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 39,825 | $154,123 | 100.00% | 0.48% |
| LION POINT CAPITAL, LP | 11/14/2024 | 39,589 | $153,209 | -56.40% | 0.48% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 25,278 | $97,841 | -14.56% | 0.30% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 19,643 | $76,018 | -28.94% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 11,858 | $45,888 | 0.00% | 0.14% |
| WEALTH ADVISORS OF IOWA, LLC | 11/12/2024 | 11,699 | $45,275 | 0.00% | 0.14% |
| STATE STREET CORP | 11/14/2024 | 11,237 | $43,487 | 0.00% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 11,130 | $43,073 | -41.25% | 0.13% |
| KEY FINANCIAL INC | 10/29/2024 | 10,927 | $42,287 | 0.00% | 0.13% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 10,000 | $38,700 | 100.00% | 0.12% |
| UBS GROUP AG | 11/14/2024 | 6,557 | $25,376 | 100.00% | 0.08% |
| PALADIN ADVISORY GROUP, LLC | 11/05/2024 | 4,387 | $16,978 | 0.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1,800 | $6,966 | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 1,225 | $4,741 | -65.80% | 0.01% |
| WEST FINANCIAL ADVISORS, LLC | 10/08/2024 | 784 | $3,035 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 290 | $1,122 | -6.45% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 166 | $642 | -40.07% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 13 | $50 | 0.00% | 0.00% |
| LIVE OAK INVESTMENT PARTNERS | 11/05/2024 | 11 | $43,000 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/12/2024 | 4 | $16 | 0.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| ATRIA INVESTMENTS, INC | 11/01/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 10/22/2024 | 0 | $0 | -100.00% | 0.00% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
Lumos Pharma, Inc.institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Lumos Pharma, Inc.. The most heavily invested institutionals were:
Private Advisor Group, LLC: 744,513
GOLDMAN SACHS GROUP INC: 362,198
VANGUARD GROUP INC: 244,082
RENAISSANCE TECHNOLOGIES LLC: 213,814
Jefferies Financial Group Inc.: 120,651
Greenwich Wealth Management LLC: 76,341
25.08% of Lumos Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.29 M shares in the last 24 months. This purchase volume represents approximately $9.92 M in transactions.